Other News To Note

Boehringer Ingelheim GmbH, of Ingelheim, Germany, acquired a biopharmaceutical development and manufacturing facility in Fremont, Calif., from Amgen Inc., of Thousand Oaks, Calif. The facility contains more than 200,000 square feet of laboratory space and employs more than 300 people.